Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Anakinra claimed for pancreatitis

June 21, 1996

FDA approval of new indication for Genentech's Activase

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

Astra's Pulmicort approaches FDA approval

June 21, 1996

FDA approval of novel Claritin formulation sought

June 21, 1996

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...